Natera (MEX:NTRA) Total Stockholders Equity: MXN31,783 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NTRA Natera Inc MEX:NTRA
50 GF Score
Price MXN5,500.00
GF Value MXN3,093.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Natera Total Stockholders Equity?

Natera MEX:NTRA 50 Total Stockholders Equity is MXN31,783 Mil as of Jun. 2026. GuruFocus rates MEX:NTRA with a GF Score™ of 50/100 and a GF Value™ of MXN3,093.57 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Natera's Total Stockholders Equity for the quarter that ended in Jun. 2026 was MXN31,783 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Natera's Book Value per Share for the quarter that ended in Jun. 2026 was MXN221.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Natera's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.13.

Natera  (MEX:NTRA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Natera's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(31783.336-0)/143.612
=221.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Natera's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1664.879 + 2496.498) / 31783.336
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natera Total Stockholders Equity Related Terms

Natera Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Natera's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natera Total Stockholders Equity Chart

Natera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,401.88 13,759.19 12,990.85 24,931.32 30,833.20

Natera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,464.61 22,970.39 30,833.20 31,990.33 31,783.34
MEX:NTRA
50GF Score
Natera Inc MEX:NTRA
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of MXN31,783 Mil mean?
Natera (MEX:NTRA) has a Total Stockholders Equity of MXN31,783 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Natera and its competitors.
Is Natera's Total Stockholders Equity too high?
Natera's current Total Stockholders Equity is MXN31,783 Mil. Overall, Natera has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Natera's Total Stockholders Equity compare to IDXX and A?
Natera's Total Stockholders Equity of MXN31,783 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Natera and its competitors. Natera's current Total Stockholders Equity is MXN31,783 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natera stock overvalued right now?
Based on GuruFocus' analysis, Natera (MEX:NTRA) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN3,093.57, compared to a current price of MXN5,500.00 — trading 77.8% above its estimated fair value. The current Total Stockholders Equity is MXN31,783 Mil. Natera's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Natera (MEX:NTRA), the current Total Stockholders Equity is MXN31,783 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natera (MEX:NTRA) Overvalued in 2026?

Based on GuruFocus' analysis, Natera stock appears to be overvalued. The current stock price of MXN5,500.00 is trading 77.8% above its estimated GF Value™ of MXN3,093.57. GuruFocus considers Natera to be Significantly Overvalued.

Key valuation signals for MEX:NTRA:

  • Total Stockholders Equity: MXN31,783 Mil
  • GF Value™: MXN3,093.57 vs. price of MXN5,500.00 (77.8% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the MEX:NTRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natera Business Description

Other Exchanges NTRA:USA45E:Germany
Address 13011 McCallen Pass, Building A Suite 100, Austin, TX, USA, 78753
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
50GF Score

Get the complete analysis for MEX:NTRA

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN5,500.00
Price
MXN3,093.57
GF Value